Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Pierre Eftekhari
Physiological Intermolecular Modification Spectroscopy for the Prediction of Response to Anti-Tumor Necrosis Factor Therapy in Patients With Inflammatory Bowel Diseases
Digestive Diseases
Medicine
Gastroenterology
Related publications
Rapid Response to Vedolizumab Therapy in Biologic-Naïve Patients With Inflammatory Bowel Diseases
Clinical Gastroenterology and Hepatology
Hepatology
Gastroenterology
Tumor Necrosis Factor Alpha in Inflammatory Bowel Disease.
Gut
Gastroenterology
Review Article: Consensus Statements on Therapeutic Drug Monitoring of Anti-Tumour Necrosis Factor Therapy in Inflammatory Bowel Diseases
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Prevalence and Pathogenesis of Anemia in Inflammatory Bowel Disease. Influence of Anti-Tumor Necrosis Factor- Treatment
Haematologica
Hematology
Editorial: CT-P13, a Biosimilar of Anti-Tumour Necrosis Factor-Alpha Agent (Infliximab), in Inflammatory Bowel Diseases
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Pgi42 - Non-Persistence With Immunosuppresant, Anti-Tumor Necrosis Factor, and Anti-Integrin Agents in Patients With Inflammatory Bowel Disease: A Retrospective Claims Data Analysis in Germany
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Prediction of Low Bone Mineral Density in Patients With Inflammatory Bowel Diseases
United European Gastroenterology Journal
Oncology
Gastroenterology
Serological Markers in Diagnosis of Pediatric Inflammatory Bowel Disease and as Predictors for Early Tumor Necrosis Factor Blocker Therapy
Scandinavian Journal of Gastroenterology
Gastroenterology
The Tumor Necrosis Factor Superfamily of Cytokines in the Inflammatory Myopathies: Potential Targets for Therapy
Clinical and Developmental Immunology